Journal Article

Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer

Di Minin, Giulio, Collavin, Licio, Bellazzo, Arianna

2017

Overview

One of the most defining features of cancer is aberrant cell communication; therefore, a molecular understanding of the intricate network established among tumor cells and their microenvironment could significantly improve comprehension and clinical management of cancer. The tumor suppressor DAB2IP (Disabled homolog 2 interacting protein), also known as AIP1 (ASK1 interacting protein), has an important role in this context, as it modulates signal transduction by multiple inflammatory cytokines and growth factors. DAB2IP is a Ras-GAP, and negatively controls Ras-dependent mitogenic signals. In addition, acting as a signaling adaptor, DAB2IP modulates other key oncogenic pathways, including TNF α /NF- κ B, WNT/ β -catenin, PI3K/AKT, and androgen receptors. Therefore, DAB2IP inactivation can provide a selective advantage to tumors initiated by a variety of driver mutations. In line with this role, DAB2IP expression is frequently impaired by methylation in cancer. Interestingly, recent studies reveal that tumor cells can employ other sophisticated mechanisms to disable DAB2IP at the post-transcriptional level. We review the mechanisms and consequences of DAB2IP inactivation in cancer, with the purpose to support and improve research aimed to counteract such mechanisms. We suggest that DAB2IP reactivation in cancer cells could be a strategy to coordinately dampen multiple oncogenic pathways, potentially limiting progression of a wide spectrum of tumors.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 631/67/1244 / 631/67/1857 / Apoptosis / Biochemistry / Biomedical and Life Sciences / Cancer / Cell Biology / Cell Cycle Analysis / Cell death / Kinases / Life Sciences / Proteins / Review / Signal transduction / Stem Cells / Tumors